These five API companies may benefit as drugmakers seek to reduce dependence on Chinese raw material

Both global and domestic drug companies are looking to diversify sourcing of Active Pharmaceutical Ingredients and Key Starting Materials from China. Indian companies, particularly pure-play API producers, are poised to tap this emerging opportunity.

from Moneycontrol Business News https://ift.tt/3lpKMmX